Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab with Methotrexate in Early Erosive Rheumatoid Arthritis
NCT00006292Phase 2Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Sep 2000
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Methotrexate + Placebo with Methotrexate + Infliximab (2 arms). Primary endpoint: Development of new erosions on MRI of the wrist at 6 months. Started Sep 2000; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00006292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006292.